126 related articles for article (PubMed ID: 32823017)
1. Corrigendum to "Cyclosporine A sensitizes human non-small cell lung cancer cells to gefitinib through inhibition of STAT3" [Canc Lett 379 (2016) 124-133].
Shou J; You L; Yao J; Xie J; Jing J; Jing Z; Jiang L; Sui X; Pan H; Han W
Cancer Lett; 2020 Nov; 493():13-15. PubMed ID: 32823017
[No Abstract] [Full Text] [Related]
2. Cyclosporine A sensitizes human non-small cell lung cancer cells to gefitinib through inhibition of STAT3.
Shou J; You L; Yao J; Xie J; Jing J; Jing Z; Jiang L; Sui X; Pan H; Han W
Cancer Lett; 2016 Aug; 379(1):124-33. PubMed ID: 27264264
[TBL] [Abstract][Full Text] [Related]
3. Corrigendum to " 2'-Hydroxyflavanone inhibits the progression of pancreatic cancer cells and sensitizes the chemosensitivity of EGFR inhibitors via repressing STAT3 signaling" [Canc. Lett. 471 (2020) 135-146].
Yue Y; Qian W; Li J; Wu S; Zhang M; Wu Z; Ma Q; Wang Z
Cancer Lett; 2022 Nov; 549():215913. PubMed ID: 36152564
[No Abstract] [Full Text] [Related]
4. Corrigendum to "Inhibition of the ʟ-glutamine transporter ASCT2 sensitizes plasma cell myeloma cells to proteasome inhibitors" [Canc. Lett. 507 (2021) 13-25].
Prelowska MK; Mehlich D; Ugurlu MT; Kedzierska H; Cwiek A; Kosnik A; Kaminska K; Marusiak AA; Nowis D
Cancer Lett; 2022 Feb; 526():363. PubMed ID: 34872789
[No Abstract] [Full Text] [Related]
5. Corrigendum to "DGKA interacts with SRC/FAK to promote the metastasis of non-small cell lung cancer" [Canc. Lett. (2022 Apr 28) 532 215585].
Fu L; Deng R; Huang Y; Yang X; Jiang N; Zhou J; Lin C; Chen S; Wu L; Cui Q; Yun J
Cancer Lett; 2022 Jul; 539():215696. PubMed ID: 35477591
[No Abstract] [Full Text] [Related]
6. Corrigendum to "Panaxynol, a natural Hsp90 inhibitor, effectively targets both lung cancer stem and non-stem cells" [Canc. Lett. 412 (2018) 297-307].
Le HT; Nguyen HT; Min HY; Hyun SY; Kwon S; Lee Y; Le THV; Lee J; Park JH; Lee HY
Cancer Lett; 2018 Jun; 424():136. PubMed ID: 29573834
[No Abstract] [Full Text] [Related]
7. Corrigendum to "UBE2T promotes radiation resistance in non-small cell lung cancer via inducing epithelial-mesenchymal transition and the ubiquitination-mediated FOXO1 degradation" [Canc. Lett. 494 (2020) 121-131].
Yin H; Wang X; Zhang X; Zeng Y; Xu Q; Wang W; Zhou F; Zhou Y
Cancer Lett; 2022 Sep; 543():215792. PubMed ID: 35718664
[No Abstract] [Full Text] [Related]
8. Corrigendum to "The Hippo/YAP1 pathway interacts with FGFR1 signaling to maintain stemness in lung cancer" [Canc. Lett. 423 (2018) 36-46].
Lu T; Li Z; Yang Y; Ji W; Yu Y; Niu X; Zeng Q; Xia W; Lu S
Cancer Lett; 2018 Sep; 431():244. PubMed ID: 29754994
[No Abstract] [Full Text] [Related]
9. Corrigendum to "FLLL12 induces apoptosis in lung cancer cells through a p53/p73-independent but death receptor 5-dependent pathway" [Canc. Lett. 363 (2015) 166-175].
Haque A; Rahman MA; Fuchs JR; Chen Z; Khuri FR; Shin DM; Amin ARMR
Cancer Lett; 2021 Feb; 498():249-250. PubMed ID: 33092912
[No Abstract] [Full Text] [Related]
10. Corrigendum to "Lung cancer survival in never-smokers and exposure to residential radon: Results of the LCRINS study" [Canc. Lett. 487 (2020) 21-26].
Casal-Mouriño A; Ruano-Ravina A; Torres-Durán M; Parente-Lamelas I; Provencio-Pulla M; Castro-Añón O; Vidal-García I; Pena-Álvarez C; Abal-Arca J; Piñeiro-Lamas M; Fuente-Merino I; Fernández-Villar A; Abdulkader I; Valdés-Cuadrado L; Barros-Dios JM; Pérez-Ríos M
Cancer Lett; 2020 Nov; 493():10. PubMed ID: 32810636
[No Abstract] [Full Text] [Related]
11. Shikonin enhances sensitization of gefitinib against wild-type EGFR non-small cell lung cancer via inhibition PKM2/stat3/cyclinD1 signal pathway.
Tang JC; Ren YG; Zhao J; Long F; Chen JY; Jiang Z
Life Sci; 2018 Jul; 204():71-77. PubMed ID: 29738778
[TBL] [Abstract][Full Text] [Related]
12. Corrigendum to "B4GALT3 up-regulation by miR-27a contributes to the oncogenic activity in human cervical cancer cells." [Canc. Lett. 375 (2016) 284-292].
Sun Y; Yang X; Liu M; Tang H
Cancer Lett; 2020 Nov; 493():16-18. PubMed ID: 32823018
[No Abstract] [Full Text] [Related]
13. Corrigendum to "Targeting autophagy in cancer stem cells as an anticancer therapy" [Canc. Lett. 393 (2017) 33-39].
Lei Y; Zhang D; Yu J; Dong H; Zhang J; Yang S
Cancer Lett; 2018 Mar; 416():149. PubMed ID: 29307478
[No Abstract] [Full Text] [Related]
14. Corrigendum to "Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer" [Canc. Lett. 438 (2018, Dec 1) 165-173].
Lin CC; Lo MC; Moody R; Jiang H; Harouaka R; Stevers N; Tinsley S; Gasparyan M; Wicha M; Sun D
Cancer Lett; 2020 Jun; 480():51. PubMed ID: 32229161
[No Abstract] [Full Text] [Related]
15. Corrigendum to "Caspase-independent cell death by allicin in human epithelial carcinoma cells: involvement of PKA."[Canc. Lett. (2005) 224 (1) 123-32].
Park SY; Cho SJ; Kwon HC; Lee KR; Rhee DK; Pyo S
Cancer Lett; 2019 Mar; 444():188. PubMed ID: 30528159
[No Abstract] [Full Text] [Related]
16. Corrigendum to "Identification of miRNomes in human stomach and gastric carcinoma reveals miR-133b/a-3p as therapeutic target for gastric cancer"[Canc. Lett. 369 (2015) 58-66].
Liu Y; Zhang X; Zhang Y; Hu Z; Yang D; Wang C; Guo M; Cai Q
Cancer Lett; 2020 Dec; 494():3-4. PubMed ID: 32827930
[No Abstract] [Full Text] [Related]
17. Activation of signal transducer and activator of transcription 3 (STAT3) signaling in EGFR mutant non-small-cell lung cancer (NSCLC).
Codony-Servat C; Codony-Servat J; Karachaliou N; Molina MA; Chaib I; Ramirez JL; de Los Llanos Gil M; Solca F; Bivona TG; Rosell R
Oncotarget; 2017 Jul; 8(29):47305-47316. PubMed ID: 28521301
[TBL] [Abstract][Full Text] [Related]
18. Corrigendum to "Identification of a CIP4 PKA phosphorylation site involved in the regulation of cancer cell invasiveness and metastasis" [Canc. Lett. 461 (2019) 65-77].
Tonucci FM; Almada E; Borini-Etichetti C; Pariani A; Hidalgo F; Rico MJ; Girardini J; Favre C; Goldenring JR; Menacho-Marquez M; Larocca MC
Cancer Lett; 2020 Mar; 473():200-201. PubMed ID: 31932121
[No Abstract] [Full Text] [Related]
19. The Effects and Mechanisms by which Saikosaponin-D Enhances the Sensitivity of Human Non-small Cell Lung Cancer Cells to Gefitinib.
Tang JC; Long F; Zhao J; Hang J; Ren YG; Chen JY; Mu B
J Cancer; 2019; 10(26):6666-6672. PubMed ID: 31777595
[TBL] [Abstract][Full Text] [Related]
20. Corrigendum to "LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9" [Canc. Lett. 410 (2017) 68-81].
Fu Z; Chen C; Zhou Q; Wang Y; Zhao Y; Zhao X; Li W; Zheng S; Ye H; Wang L; He Z; Lin Q; Li Z; Chen R
Cancer Lett; 2022 Oct; 545():215836. PubMed ID: 35934602
[No Abstract] [Full Text] [Related]
[Next] [New Search]